期刊文献+

乳腺癌复发和转移的相关因素研究 被引量:6

Study of related factors on breast cancer recurrence and metastasis
下载PDF
导出
摘要 目的探讨影响乳腺癌复发转移的因素。方法 100例乳腺癌患者中,采取传统式根治手术患者19例,改良式根治手术患者47例,扩大式根治手术患者29例,乳房单纯切除手术患者3例,区段式切除手术患者2例。对患者的肿瘤直径、淋巴结转移数、年龄以及癌抗原135等相关指标进行分析。结果单纯乳房切除手术患者的复发转移率最高,与其他治疗方法比较,差异有统计学意义(P<0.05)。对比不同年龄段的患者复发转移率,差异有统计学意义(P<0.05)。肿瘤直径低于2 cm的患者与肿瘤直径超过5 cm的患者比较,差异有统计学意义(P<0.05)。与1~3个淋巴结转移以及超过3个淋巴结转移的患者相比,无淋巴结转移患者的复发转移率较低,差异有统计学意义(P<0.05)。癌抗原135(CA135)阳性患者与阴性患者复发转移率相对比,差异具有统计学意义(P<0.05)。乳腺癌复发转移与患者的肿瘤直径以及淋巴结转移数呈现正相关关系,而乳腺癌复发转移与患者的癌抗原135以及患者的年龄呈现负相关关系。结论淋巴结转移数、癌抗原135、年龄及肿瘤直径与乳腺癌复发转移关系密切,淋巴结转移数为最主要影响因素。 Objective To investigated the related factors on breast cancer recurrence and metastasis. Methods Of 100 breast cancer patients, 19 underwent traditional radical operation, 47 modified radical operation,29 enlarged radical operation, 3 merely resection operation, and 2 segmental resection operation. Index like tumor diameter, metastatic lymph node number, age, cancer antigen 135 ( CA135 ), etc were analyzed. Results Of all patients with breast cancer, the recurrent metastatic rate was the highest in the patients underwent simple operation treatment (P 〈 0.05 ). As for the comparison of recurrence rate of different ages,the difference was statistically significant (P 〈 0.05 ). Patients with tumor diameter tess than 2cm and tumor diameter over 5cm were showed with different recurrence rate. Compared with patients with 1 - 3 lymph node metastases and the patients with more than 3 lymph node metastases. Recurrent metastatic rate in the patients with no lymph node metastasis was lower, the difference was statistically significant (P 〈 0.05 ). There was statistical significant difference in recurrence and metastasis rate between CA135 positive and nezativepatients (P 〈 0.05 ). Recurrence and metastasis were positively related to tumor diameters and lymph node metastasis number, but negatively related to CA135 and age. Conclusion It seems that the number of lymph nodes metastasis,CA 135, age and tumor diameter are closely related to recurrence and metastasis of breast cancer, and among them, number of lymph nodes metastasis is the dominant influence factor.
作者 李戎
出处 《微创医学》 2012年第6期600-602,共3页 Journal of Minimally Invasive Medicine
关键词 乳腺癌 复发 转移 相关因素 Breast cancer Recurrence Metastasis Related factors
  • 相关文献

参考文献5

二级参考文献42

  • 1赵丽娟,汪静,杨金巧.新辅助化疗对乳腺癌ER、PR、pS2、C-erbB-2、Ki-67表达的影响[J].华西医学,2008,23(5):1006-1008. 被引量:3
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 3赵力,马丽君,宋晨.乳腺癌治疗后早期转移多因素分析[J].中国综合临床,2006,22(7):644-645. 被引量:4
  • 4宋艳利,王东.新辅助化疗对Ⅱ期乳腺癌的疗效观察[J].中国肿瘤临床,2007,34(7):411-412. 被引量:7
  • 5Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence [ J ]. Clin Cancer Res, 2007, 13(15Ptl): 4429-4434.
  • 6Lin NU, Claus E, Sohl J, et al. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases [ J ] . Cancer, 2008, 113(10): 2638-2645.
  • 7Srivastava N, Gochhait S, de Boer P, et al. Role of H2AX in DNA damage response and human cancers [ J ] . Mutat Res, 2009, 681(2-3): 180-188.
  • 8Ziogas D, Liakakos T, Lykoudis E, et al. Exploring the role of BRCA1, BRCA2 and RAD51 as biomarkers for breast cancer [ J ] . Radiother Oncol, 2009, 90(1): 161-162.
  • 9Tommiska J, Bartkova J, Heinonen M, et al. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/ BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer [ J ] . Oncogene, 2008, 27(17): 2501-2506.
  • 10Weberpals JI, Clark-Knowles KV, Vanderhyden BC. Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway [ J ] . J Clin Oncol, 2008, 26(19): 3259-3267.

共引文献37

同被引文献53

  • 1van de Water W,Markopoulos C.Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer[J].JAMA,2012 ;307:590-7.
  • 2van de Velde CJH,Rea D,Seynaeve C,et al.Adjuvant tamoxifen and exemestane in early breast cancer (TEAM):A randomised phase 3 trial[J].Lancet,2011 ;377:321-31.
  • 3Fisher B,Bryant J,Dignam J J,et al.Tamoxifen,radiation therapy,or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less[J].J Clin Oncol,2002 ;20:4141-9.
  • 4Courdi A,Largillier R,Ferrero JM,et al.Early versus late local recurrences after conservative treatment of breast carcinoma:Differences in primary tumor characteristics and patient outcome[J].Oncology,2006 ;71:361-8.
  • 5Zhang BN, Zhang B, Tang ZH, et al. 10-year ehanges and development of surgical treatment for breast cancer in Chin[J].Zhonghua Zhong Liu Za Zhi,2012,34(8) . 582-587.
  • 6Bourhafour M,Belbaraka R,Souadka A,et al.Male breast cancer:a report of 127 cases at a Moroccan institution[J].BMC Res Notes,2011,4:219.
  • 7Ottini L,Silvestri V,Rizzolo P,et al.Clinical and pathological characteristics of BRCA-positive and BRCA-negative male breast cancer patients:results from a collaborative multicenter study in Italy[J].Breast Cancer Res Treat,2012,134(1):411-418.
  • 8Sánchez-Mu觡oz A,Román-Jobacho A,Pérez-Villa L,et al.Male breast cancer:immunohistochemical subtypes and clinical outcome characterization[J].Oncology,2012,83(4):228-233.
  • 9Cutuli B,Le-Nir CC,Serin D,et al.Male breast cancer.Evolution of treatment and prognostic factors:analysis of 489 cases[J].Crit Rev Oncology Hematol,2010,73(3):246-254.
  • 10刘晓雁,林毅,司徒红林.乳腺癌复发危险因素评估及中医既病防变策略[J].辽宁中医杂志,2008,35(10):1499-1501. 被引量:7

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部